Phathom Pharmaceuticals, Inc. announced the appointment of Frank Karbe to its Board of Directors. Mr. Karbe, who most recently served as President and Chief Financial Officer of Myovant Sciences, Inc., brings over twenty-five years of financial and life-sciences expertise to Phathom.